COVID-19 Vaccination Detoxification in LDL-C

COVID-19 Respiratory Infection Clinical Trial

Official title: COVID-19 Vaccination Detoxication in Low Density Lipoprotein Cholesterol

Status Active, not recruiting

Clinical Trial Summary

The study hypothesizes that SARS-CoV-2 vaccination poisoning hibernates in human host in Low Density Lipoprotein Cholesterol (LDL-C). The clinical trial is a follow-up from the intervention trial with NCT number NCT05711810. It tests the use of Atorvastatin Calcium Tablets for detoxification and prevention of blood acidification, and the use of the Chinese herb compounded Anti-Viral Granules for the detoxification in the endocrine system.

Clinical Trial Description

n/a

Related Conditions & MeSH terms

• COVID-19
• Respiratory Tract Infections
• Syndrome
• Thromboembolism

• NCT number: NCT05839236
• Study type: Interventional
• Source: Pachankis, Yang I., M.D.
• Status: Active, not recruiting
• Phase: Phase 1
• Start date: May 1, 2023
• Completion date: July 31, 2023